Global Emphysema Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Emphysema Market Expected To Become By 2029 Compared With Its 2025 Level?

The emphysema market has shown consistent expansion in recent years. Its valuation is anticipated to increase from $4.74 billion in 2024 to $4.94 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.3%. The expansion observed historically is attributable to factors like the rising occurrence of respiratory conditions, an enlarging elderly demographic, heightened tobacco use, escalating atmospheric contamination, intensified governmental programs, and a larger populace involved in tobacco consumption.

The emphysema market is projected to experience consistent expansion over the next few years, with its valuation anticipated to reach $5.91 billion by 2029, growing at a compound annual growth rate (CAGR) of 4.6%. This projected growth during the forecast period is largely attributable to factors such as heightened healthcare expenditures, rising environmental pollution, a greater demand for diagnostic medical devices, increasing vehicular traffic, and the growing preference for minimally invasive procedures. Significant trends expected in the forecast period include the emergence of new inhalation devices, strategic collaborations, advancements in personalized medicine, the rise of telemedicine, improvements in inhalation therapies, and ongoing medical progress.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21956&type=smp

What Are The Key Drivers Of Growth In The Emphysema Market?

The anticipated expansion of the emphysema market is attributed to the rising occurrence of respiratory infections, which are defined as infections impacting the respiratory system, including the sinuses, throat, airways, and lungs. The increase in these infections stems from factors such as pollution, climate change, antimicrobial resistance, urbanization, and evolving pathogens. Respiratory infections accelerate emphysema progression by causing inflammation, tissue damage, and increased airway obstruction, thereby worsening lung function. For instance, in November 2024, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2023, the U.S. reported 9,633 tuberculosis (TB) cases, a 15.6% rise from 8,332 in 2022, with the incidence rate increasing 15.0% from 2.5 to 2.9 per 100,000 persons. Consequently, the growing prevalence of respiratory infections is a significant driver for the growth of the emphysema market.

What Are The Emerging Segments Gaining Attention In The Emphysema Market?

The emphysemamarket covered in this report is segmented –

1) By Type: Centrilobular; Panlobular

2) By Treatment: Medication; Therapy; Surgery; Other Treatments

3) By Diagnosis: Imaging Test; Lung Function Test; Other Diagnosis

4) By Complications: Chest Infections; Collapsed Lung; Heart Problems; Lungs Hole; Other Complications

5) By End-user: Hospitals And Clinics; Surgical Center; Other End-users

Subsegments:

1) By Centrilobular: Mild Centrilobular Emphysema; Moderate Centrilobular Emphysema; Severe Centrilobular Emphysema

2) By Panlobular: Mild Panlobular Emphysema; Moderate Panlobular Emphysema; Severe Panlobular Emphysema

Which Ongoing Trends Are Expected To Shape The Emphysema Market Outlook?

Key companies within the emphysema market are concentrating on medical breakthroughs, such as inhaled dual inhibitors of phosphodiesterase 3 and phosphodiesterase 4, to offer patients advanced treatments that boost lung function, lessen inflammation, and improve overall disease management, thereby fostering superior respiratory health and quality of life. An inhaled dual inhibitor of phosphodiesterase 3 and phosphodiesterase 4 is a medication designed to target and block both phosphodiesterase enzymes in the lungs, which helps relax airways and reduce inflammation, subsequently improving breathing in conditions like chronic obstructive pulmonary disease. As an illustration, in June 2024, Verona Pharma plc, a UK-based pharma company, launched Ohtuvayre (ensifentrine), which is the first inhaled dual PDE3 and PDE4 inhibitor approved by the Food and Drug Administration, a US-based federal agency, for the maintenance treatment of chronic obstructive pulmonary diseases like emphysema, signifying the first novel inhaled therapy in over 20 years. This drug, which provides both bronchodilator and anti-inflammatory benefits, is slated for availability through specialty pharmacies.

Who Are The Major Companies Operating In The Emphysema Market?

Major companies operating in the emphysema market are Pfizer Inc., Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim, Mylan N.V., Olympus Corporation, ResMed Inc., Chiesi Farmaceutici S.p.A., University of Chicago Medicine (UChicago Medicine), Hikma Pharmaceuticals PLC, United Therapeutics Corporation, VIDA Diagnostics Inc., Kamada Limited, Pulmonx Corporation, Mereo BioPharma Group PLC, Uptake Medical Corporation, Verona Pharma PLC.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/emphysema-global-market-report

What Are The Key Regional Factors Influencing The Emphysema Market Growth?

North America was the largest region in the emphysema market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the emphysema market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Emphysema Market Report:

https://www.thebusinessresearchcompany.com/customise?id=21956&type=smp

Browse Through More Reports Similar to the Global Emphysema Market 2025, By The Business Research Company

Emphysema Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report

Lung Cancer Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lung-cancer-drugs-global-market-report

Lung Cancer Diagnostic And Screening Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/lung-cancer-diagnostic-and-screening-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795